NCT05315661View on ClinicalTrials.gov

The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 6, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Frontotemporal Dementia

Interventions

DRUG

ET-STEM

mesenchymal stem cells preconditioned with ethionamide

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER